ROBERT KRANCE to Drug Resistance, Neoplasm
This is a "connection" page, showing publications ROBERT KRANCE has written about Drug Resistance, Neoplasm.
Connection Strength
0.029
-
Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease. Hum Gene Ther. 2000 Jul 01; 11(10):1465-75.
Score: 0.029